# Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/sustained-response-with-ixekizumab-treatment-of-moderate-to-severe-psoriasis/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kristian Reich,Craig L. Leonardi,Mark Lebwohl,Francisco A. Kerdel,Yukari Okubo,Ricardo Romiti,Orin M. Goldblum,Ellen B. Dennehy,Lisa Kerr,Howard Sofen |
| Citations | 57 |
| DOI | 10.1080/09546634.2016.1249820 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://figshare.com/articles/journal_contribution/Sustained_response_with_ixekizumab_treatment_of_moderate-to-severe_psoriasis_with_scalp_involvement_results_from_three_phase_3_trials_UNCOVER-1_UNCOVER-2_UNCOVER-3_/4231835 |
| OpenAlex ID | https://openalex.org/W2533556733 |
| PMID | 27759463 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Orin M. Goldblum](https://scholariq.org/researchers/orin-m-goldblum/)

## Paper primary topic

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

## Paper topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.